G. Michael Besser

G. Michael Besser's AcademicInfluence.com Rankings

G. Michael Besser

Philosophy

#3558

World Rank

#5722

Historical Rank

Logic

#1239

World Rank

#1934

Historical Rank

philosophy Degrees

G. Michael Besser

Biology

#4465

World Rank

#6649

Historical Rank

Endocrinology

#32

World Rank

#36

Historical Rank

Molecular Biology

#344

World Rank

#350

Historical Rank

Biochemistry

#460

World Rank

#542

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

G. Michael Besser's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biochemistry University of California, San Francisco

Why Is G. Michael Besser Influential?

(Suggest an Edit or Addition)

(See a Problem?)

G. Michael Besser's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome (2002) (658)
The diagnosis and medical management of advanced neuroendocrine tumors. (2004) (656)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist (2001) (591)
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. (1974) (555)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. (2000) (499)
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (1996) (454)
Characterization of mutations in patients with multiple endocrine neoplasia type 1. (1998) (426)
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. (2006) (417)
INCREASED β-ENDORPHIN BUT NOT MET-ENKEPHALIN LEVELS IN HUMAN CEREBROSPINAL FLUID AFTER ACUPUNCTURE FOR RECURRENT PAIN (1980) (381)
HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MAN (1978) (362)
Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. (1991) (355)
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. (1995) (343)
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. (1989) (340)
Long-term Treatment of Galactorrhoea and Hypogonadism with Bromocriptine (1974) (312)
Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine (1972) (307)
DIAGNOSIS AND MANAGEMENT OF ACTH‐DEPENDENT CUSHING'S SYNDROME: COMPARISON OF THE FEATURES IN ECTOPIC AND PITUITARY ACTH PRODUCTION (1986) (287)
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. (1973) (271)
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. (2001) (268)
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment (1993) (266)
Failure to preserve fertility in patients with Hodgkin's disease (2004) (255)
Thyrotrophin-releasing hormone as a thyroid-function test. (1971) (254)
Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. (1995) (248)
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. (1974) (247)
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. (1998) (234)
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. (1984) (227)
Long-term treatment of acromegaly with bromocriptine. (1977) (227)
Met-enkephalin circulates in human plasma (1980) (225)
A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. (1999) (223)
Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. (2000) (203)
Cushing's syndrome. (1972) (197)
ACUPUNCTURE IN HEROIN ADDICTS: CHANGES IN MET-ENKEPHALIN AND β-ENDORPHIN IN BLOOD AND CEREBROSPINAL FLUID (1979) (188)
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. (1999) (188)
NEW HYPOTHALAMIC HORMONE, CORTICOTROPIN-RELEASING FACTOR, SPECIFICALLY STIMULATES THE RELEASE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN MAN (1982) (184)
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. (1996) (181)
Gonadotrophin-releasing Hormone Therapy in Hypogonadal Males with Hypothalamic or Pituitary Dysfunction (1974) (180)
The adrenocortical response to surgery and insulin‐induced hypoglycaemia in corticosteroid‐treated and normal subjects (1969) (172)
An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year (1994) (171)
THE OPIOID CONTROL OF LH AND FSH RELEASE: EFFECTS OF A MET‐ENKEPHALIN ANALOGUE AND NALOXONE (1981) (171)
Luteinizing Hormone and Follicle Stimulating Hormone-Releasing Hormone Test in Patients with Hypothalamic Pituitary-Gonadal Dysfunction (1973) (170)
Methodological Considerations in the Determination of Plasma Catecholamines by High-Performance Liquid Chromatography with Electrochemical Detection (1985) (166)
DIRECT INHIBITION OF GASTRIC ACID AND PEPSIN SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN CATS (1975) (163)
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. (1972) (162)
REDUCTION OF PITUITARY-TUMOUR SIZE IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALY TREATED WITH BROMOCRIPTINE WITH OR WITHOUT RADIOTHERAPY (1979) (162)
Modulation of 11β-Hydroxysteroid Dehydrogenase Isozymes by Growth Hormone and Insulin-Like Growth Factor: In Vivo and In Vitro Studies1 (1999) (156)
Bromocriptine treatment of acromegaly. (1975) (154)
Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. (1979) (154)
MRI of pancreatic neuroendocrine tumours. (2001) (153)
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. (2003) (151)
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. (1975) (150)
β-ENDORPHIN IN HUMAN CEREBROSPINAL FLUID (1978) (149)
CORTICOTROPHIN RELEASING FACTOR: RESPONSES IN NORMAL SUBJECTS AND PATIENTS WITH DISORDERS OF THE HYPOTHALAMUS AND PITUITARY (1984) (148)
Growth Hormone Release Inhibiting Hormone in Acromegaly (1974) (145)
Metyrapone in long-term management of Cushing's disease. (1977) (144)
Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reports (1989) (144)
The role of opioid peptides in the hormonal responses to acute exercise in man. (1984) (143)
Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. (2000) (143)
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. (1980) (142)
Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur. (1997) (141)
Pituitary-adrenal function in severe depressive illness. (1968) (138)
Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. (1982) (137)
Measurement of circulating corticotrophin-releasing factor in man. (1987) (136)
MEGAVOLTAGE PITUITARY IRRADIATION IN THE MANAGEMENT OF CUSHING'S DISEASE AND NELSON'S SYNDROME: LONG‐TERM FOLLOW‐UP (1989) (135)
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer. (1985) (135)
Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. (1998) (133)
Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory Studies (1973) (133)
Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours (1998) (130)
The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. (1996) (128)
Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. (2001) (127)
AIP mutation in pituitary adenomas in the 18th century and today. (2011) (127)
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. (2003) (127)
Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. (1971) (124)
Glucagon control of fasting glucose in man. (1974) (123)
GH FEEDBACK OCCURS THROUGH MODULATION OF HYPOTHALAMIC SOMATOSTATIN UNDER CHOLINERGIC CONTROL: STUDIES WITH PYRIDOSTIGMINE AND GHRH (1987) (122)
Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. (2002) (122)
The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. (1995) (121)
Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. (2005) (121)
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy. (2001) (118)
Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. (1988) (115)
Bromocriptine treatment of female infertility: report of 13 pregnancies. (1975) (113)
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors. (1998) (111)
Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. (2003) (111)
Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. (1996) (111)
Development and Validation of a Specific Radioimmunoassay for Somatostatin in Human Plasma (1979) (111)
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. (1983) (111)
STUDIES ON CIRCULATING MET‐ENKEPHALIN AND β‐ENDORPHIN: NORMAL SUBJECTS AND PATIENTS WITH RENAL AND ADRENAL DISEASE (1981) (110)
Amenorrhoea, Galactorrhoea, and Primary Hypothyroidism with High Circulating Levels of Prolactin (1971) (110)
Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. (1998) (109)
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours (2006) (109)
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. (1998) (106)
Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine (1970) (105)
TUMOUR AND PLASMA ACTH CONCENTRATIONS IN PATIENTS WITH AND WITHOUT THE ECTOPIC ACTH SYNDROME (1972) (105)
INTERACTION BETWEEN SECRETION OF THE GONADOTROPHINS, PROLACTIN, GROWTH HORMONE, THYROTROPHIN AND CORTICOSTEROIDS IN MAN: THE EFFECTS OF LH/FSH‐RH, TRH AND HYPOGLYCAEMIA ALONE AND IN COMBINATION (1973) (103)
Psychotic reactions during treatment of pituitary tumours with dopamine agonists. (1984) (102)
Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. (1997) (100)
Serum cytokines in thyrotoxicosis. (1999) (100)
How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? (2000) (99)
The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. (1999) (99)
Bromocriptine in management of large pituitary tumours. (1982) (97)
Proceedings: Effect of somatostatin on motilin levels and gastric emptying. (1975) (96)
The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. (2003) (95)
Corticosteroid treatment and surgery (1969) (95)
Hormonal Responses to Synthetic Luteinizing Hormone and Follicle Stimulating Hormone-Releasing Hormone in Man (1972) (94)
PULSATILE GONADOTROPHIN SECRETION IN HYPERPROLACTINAEMIC AMENORRHOEA AND THE RESPONSE TO BROMOCRIPTINE THERAPY (1982) (94)
Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome (1995) (94)
Menstrual irregularity in women with acromegaly. (1999) (93)
OPIATE MODULATION OF THE PITUITARY‐ADRENAL AXIS: EFFECTS OF STRESS AND CIRCADIAN RHYTHM (1982) (92)
OPIATES CONTROL ACTH THROUGH A NORADRENERGIC MECHANISM (1982) (91)
OPIATE MEDIATION OF AMENORRHOEA IN HYPERPROLACTINAEMIA AND IN WEIGHT‐LOSS RELATED AMENORRHOEA (1982) (91)
Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects (1981) (91)
INHIBITION OF THE PLASMA-ALDOSTERONE RESPONSE TO FRUSEMIDE BY BROMOCRIPTINE (1975) (91)
GROWTH-HORMONE-RELEASING FACTOR IN GROWTH HORMONE DEFICIENCY: DEMONSTRATION OF A HYPOTHALAMIC DEFECT IN GROWTH HORMONE RELEASE (1983) (90)
Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. (1987) (89)
Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome. (2001) (88)
THE EFFECTS OF DOPAMINE, BROMOCRIPTINE, LERGOTRILE AND METOCLOPRAMIDE ON PROLACTIN RELEASE FROM CONTINUOUSLY PERFUSED COLUMNS OF ISOLATED RAT PITUITARY CELLS (1979) (88)
ANGIOTENSIN II STIMULATES THE RELEASE OF ACTH FROM DISPERSED RAT ANTERIOR PITUITARY CELLS (1981) (88)
Isolated Pituitary Gonadotrophin Deficiency: Gonadotrophin Secretion after Synthetic Luteinizing Hormone and Follicle Stimulating Hormone-releasing Hormone (1972) (87)
CIRCULATING SOMATOSTATIN AFTER FOOD AND GLUCOSE IN MAN (1980) (87)
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. (2002) (87)
CRF IN THE DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME: A COMPARISON WITH THE DEXAMETHASONE SUPPRESSION TEST (1988) (86)
RESPONSES TO ANALOGUES OF GROWTH HORMONE‐RELEASING HORMONE IN NORMAL SUBJECTS, AND IN GROWTH‐HORMONE DEFICIENT CHILDREN AND YOUNG ADULTS (1984) (86)
Gallstones during octreotide therapy. (1992) (86)
FREE‐RUNNING CIRCADIAN PLASMA CORTISOL RHYTHM IN A BLIND HUMAN SUBJECT (1979) (86)
Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. (2003) (85)
Megavoltage pituitary irradiation in the management of prolactinomas: long‐term follow‐up (1991) (85)
CHANGES IN CIRCULATING SOMATOMEDIN‐C LEVELS IN BROMOCRIPTINE‐TREATED ACROMEGALY (1982) (84)
NALOXONE INHIBITS EXERCISE‐INDUCED RELEASE OF PRL AND GH IN ATHLETES (1983) (84)
Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. (1993) (83)
STUDIES OF THE OPIATE CONTROL OF PROLACTIN, GH AND TSH (1981) (83)
Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth (1996) (82)
Predictors and rates of treatment-resistant tumor growth in acromegaly. (2005) (82)
Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease. (2011) (82)
Influence of gastric emptying-rate and of insulin response on oral glucose tolerance in thyroid disease. (1968) (82)
Linear growth and final height after treatment for Cushing's disease in childhood. (2000) (81)
High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. (1984) (81)
CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome. (1999) (81)
GROWTH HORMONE PRETREATMENT IN MAN BLOCKS THE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE; EVIDENCE FOR A DIRECT EFFECT OF GROWTH HORMONE (1987) (80)
Unilateral renal aplasia in X‐linked Kallmann's syndrome (1994) (80)
Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris (1982) (80)
Cushing’s Disease in Childhood: Presentation, Investigation, Treatment and Long-Term Outcome (2001) (79)
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. (2001) (78)
A Specific Radioimmunoassay for Human β-Lipotropin* (1978) (78)
INHIBITION OF VASOPRESSIN RELEASE IN MAN BY AN OPIATE PEPTIDE (1980) (77)
TREATMENT OF GROWTH-HORMONE DEFICIENCY WITH GROWTH-HORMONE-RELEASING HORMONE (1987) (77)
The influence of gender on the short and long‐term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5‐year study (2001) (76)
Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro (1989) (75)
The Pathology of Median Neuropathy in Acromegaly (2000) (75)
Influence of amphetamines on plasma corticosteroid and growth hormone levels in man (1969) (74)
The prevalence and characteristic features of cyclicity and variability in Cushing's disease. (2009) (73)
A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo‐pituitary‐adrenal axis in the early post‐operative period after hypophysectomy (1997) (73)
AUTOIMMUNE CRANIAL DIABETES INSIPIDUS: ITS ASSOCIATION WITH OTHER ENDOCRINE DISEASES AND WITH HISTIOCYTOSIS X (1986) (72)
Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones (1999) (72)
Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. (2004) (71)
Pregnancy in patients presenting with hyperprolactinaemia. (1979) (70)
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study (2000) (69)
'Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesis. (2000) (69)
CORTICOTROPIN-RELEASING FACTOR IMMUNOREACTIVITY IN HUMAN GASTROINTESTINAL TRACT (1982) (68)
Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. (1996) (68)
Neurosurgical treatment of Nelson's syndrome. (2002) (68)
A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. (1995) (68)
THE RELATIONSHIP BETWEEN CIRCADIAN VARIATIONS IN CIRCULATING THYROTROPHIN, THYROID HORMONES AND PROLACTIN (1978) (67)
Long-term Infusion of Growth Hormone Release Inhibiting Hormone in Acromegaly: Effects on Pituitary and Pancreatic Hormones (1974) (67)
ACTH and α-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central–peripheral melanocortin-leptin pathway (2003) (66)
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. (2005) (65)
Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. (1984) (65)
Progesterone-Induced Erythema Multiforme (1985) (65)
THE CORTISOL RESPONSE TO CORTICOTROPHIN‐RELEASING FACTOR IS BLUNTED IN OBESITY (1988) (64)
Serum lipoprotein changes following IGF‐I normalization using a growth hormone receptor antagonist in acromegaly (2002) (63)
The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. (1994) (63)
The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. (2003) (62)
Plasma Prolactin Activity in Inappropriate Lactation (1971) (62)
CHROMATOGRAPHIC CHARACTERIZATION OF ADRENOCORTICOTROPHIN IN HUMAN PLASMA (1980) (62)
THE EFFECT OF NALOXONE ON PULSATILE GONADOTROPHIN RELEASE IN NORMAL SUBJECTS (1981) (62)
THE EFFECTS OF A MET‐ENKEPHALIN ANALOGUE ON ACTH, β‐LPH, β‐ENDORPHIN AND MET‐ENKEPHALIN IN PATIENTS WITH ADRENOCORTICAL DISEASE (1981) (60)
AN ASSESSMENT OF GLUCOSE INTOLERANCE IN ACROMEGALY AND ITS RESPONSE TO MEDICAL TREATMENT (1980) (60)
The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. (1989) (60)
BILATERAL TESTICULAR TUMOURS IN CONGENITAL ADRENAL HYPERPLASIA: A CONTINUING DIAGNOSTIC AND THERAPEUTIC DILEMMA (1989) (59)
Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in-vitro release from hypothalamic explants. (1989) (58)
Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. (2003) (58)
A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor. (1987) (58)
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. (1993) (58)
The clinical relevance of classes of immunoglobulins on spermatozoa from infertile and vasovasostomized males. (1985) (58)
FOOD‐INDUCED CORTISOL SECRETION IS MEDIATED BY CENTRAL ALPHA‐1 ADRENOCEPTOR MODULATION OF PITUITARY ACTH SECRETION (1987) (58)
Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. (1991) (56)
THE EFFECT OF DOPAMINE AGONIST THERAPY ON LARGE FUNCTIONLESS PITUITARY TUMOURS (1985) (56)
The Bart's endocrine protocols (1995) (56)
Immunocytochemical study of 18 tumours causing ectopic Cushing's syndrome. (1986) (56)
Malignant prolactinoma with extracranial metastases: a report of three cases (1993) (55)
Letter: Metaclopramide and prolactin. (1974) (55)
Endocrine and metabolic diseases. Adrenal diseases. (1976) (55)
Simultaneous release of neurotensin, somatostatin, enkephalins and catechol-amines from perfused cat adrenal glands (1982) (55)
Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone. (1975) (55)
Differential stimulation of corticol and dehydropiandrosterone levels by food in obese and normal subjects: relation to body fat distribution (1996) (54)
The effect of an opiate antagonist on the hormonal changes induced by hexarelin (1995) (54)
Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy (1996) (54)
Plasma Levels of Immunoreactive Corticotrophin in Patients with Cushing's Syndrome (1968) (53)
PROLACTINOMAS PRESENTING AS PRIMARY AMENORRHOEA AND DELAYED OR ARRESTED PUBERTY: RESPONSE TO MEDICAL THERAPY (1989) (53)
Immunoreactive Corticotrophin Levels in Adrenocortical Insufficiency (1971) (52)
Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. (1990) (52)
Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release. (1986) (52)
Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism * (1994) (52)
Corticosteroid treatment and surgery. 1. An investigation of the indications for steroid cover. (1970) (51)
Endogenous opioids modulate the cardiovascular response to mental stress (1990) (51)
PITUITARY ACTH DEPENDENT CUSHING'S SYNDROME DUE TO ECTOPIC PRODUCTION OF A BOMBESIN‐LIKE PEPTIDE BY A MEDULLARY CARCINOMA OF THE THYROID (1985) (50)
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. (1999) (50)
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist. (2001) (50)
Experience with selective venous sampling in diagnosis of ACTH-dependent Cushing's syndrome. (1982) (50)
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia. (1992) (49)
Gonadotropin-releasing hormone immunoreactivity in the nasal epithelia of adults with Kallmann's syndrome and isolated hypogonadotropic hypogonadism and in the early midtrimester human fetus. (1997) (49)
Plasma and 24 H-Urinary Catecholamine Concentrations in Normal and Patient Populations (1993) (49)
Ectopic production of methionine enkephalin and beta-endorphin. (1980) (48)
Hypothalamic regulatory hormones: a review. (1974) (47)
Androgen status in women with late onset or persistent acne vulgaris (1984) (47)
Hypothalamus as an endocrine organ--I. (1974) (47)
Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease. (1977) (47)
Cyclic prednisolone therapy for male infertility associated with autoantibodies to spermatozoa. (1986) (47)
Response of luteinizing hormone from columns of dispersed rat pituitary cells to a highly potent analogue of luteinizing hormone releasing hormone. (1981) (47)
THE RELATIONSHIP BETWEEN SERUM PROLACTIN AND IMMUNOCYTOCHEMICAL STAINING FOR PROLACTIN IN PATIENTS WITH PITUITARY MACROADENOMAS (1985) (46)
Lymphocytic hypophysitis: unusual features of a rare disorder (1995) (46)
ENDOCRINE FUNCTION IN THE PRADER‐WILLI SYNDROME (1980) (46)
Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man. (1978) (46)
Diseases of the hypothalamus and pituitary gland. (1974) (45)
REDUCED‘GONADOTROPHS RESPONSE TO RELEASING HORMONE’AFTER CHRONIC ADMINISTRATION TO IMPOTENT MEN (1977) (45)
Characterization of pro-opiomelanocortin-derived peptides in pituitary and ectopic adrenocorticotrophin-secreting tumours. (1986) (45)
A comparison of the clearance of ovine and human corticotrophin-releasing hormone (CRH) in man and sheep: a possible role for CRH-binding protein. (1992) (44)
Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. (1996) (44)
Primary hyperaldosteronism (Conn syndrome): MR imaging findings. (2000) (44)
Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants. (1992) (44)
Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. (1984) (43)
Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn’s syndrome) (2004) (43)
Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro (1991) (43)
STIMULATION BY FOOD OF PERIPHERAL PLASMA IMMUNOREACTIVE GROWTH HORMONE RELEASING FACTOR (1985) (43)
Interleukin‐6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study (1992) (43)
IMPAIRMENT OF PLATELET FUNCTION BY GROWTH-HORMONE RELEASE- INHIBITING HORMONE (1975) (43)
Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status. (1992) (43)
TRANSIENT AMAUROSIS AND HEADACHE AFTER THYROTROPIN RELEASING HORMONE (1982) (43)
MOLECULAR FORMS OF SOMATOSTATIN IN NORMAL SUBJECTS AND IN PATIENTS WITH PANCREATIC SOMATOSTATINOMA (1980) (41)
GABA and muscimol inhibit the release of prolactin from dispersed rat anterior pituitary cells. (1981) (41)
ALCOHOL-INDUCED PSEUDO-CUSHING'S SYNDROME (1977) (41)
Clinical perspectives in opioid peptides. (1983) (40)
The radiological investigation of occult ectopic ACTH-dependent Cushing's syndrome. (1993) (40)
Prolactinomas (1985) (40)
Heterogeneous immunocytochemical reactivities of oCRF-41-like material in the human hypothalamus, pituitary and gastrointestinal tract. (1984) (40)
Changes in pituitary hormone levels induced by met-enkephalin in man--the role of dopamine. (1981) (40)
INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS AND INTRANASAL ADMINISTRATION OF LH/FSH‐RH: THE DURATION OF EFFECT AND OCCURRENCE OF ASYNCHRONOUS PULSATILE RELEASE OF LH AND FSH (1974) (39)
The relationship between cortisol production rate and serial serum Cortisol estimation in patients on medical therapy for Cushing's syndrome (1993) (39)
Comprehensive clinical endocrinology (2002) (39)
Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide. (2002) (39)
Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers (1992) (38)
A DOUBLE BLIND CROSS OVER TRIAL OF GONADOTROPHIN RELEASING HORMONE (LHRH) IN SEXUALLY IMPOTENT MEN (1976) (38)
Bombesin-like peptides in human endocrine tumors: quantitation, biochemical characterization, and secretion. (1985) (37)
Corticosteroid treatment and surgery (1969) (37)
OPIATE PEPTIDES CONTROL GROWTH HORMONE THROUGH A CHOLINERGIC MECHANISM IN MAN (1983) (37)
THE TSH, FSH AND PROLACTIN RESPONSES TO CONTINUOUS INFUSIONS OF TRH AND THE EFFECTS OF OESTROGEN ADMINISTRATION IN NORMAL MALES (1974) (37)
DEPOT‐BROMOCRIPTINE TREATMENT FOR PROLACTINOMAS AND ACROMEGALY (1986) (36)
Response to stress. (1970) (36)
COMPARISON OF THE CLINICAL ACTIVITY OF MESULERGINE AND PERGOLIDE IN THE TREATMENT OF HYPERPROLACTINAEMIA (1985) (36)
THE INTERACTION OF GROWTH HORMONE RELEASING HORMONE WITH OTHER HYPOTHALAMIC HORMONES ON THE RELEASE OF ANTERIOR PITUITARY HORMONES (1986) (36)
Pro-opiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome. (1989) (36)
Corrigendum: Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (Q J Med (1996) 89 (653-659)) (1996) (35)
Female pseudohermaphroditism due to a maternal adrenocortical tumor. (1990) (35)
Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. (2007) (35)
Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy. (2009) (35)
Value of computed tomography of the abdomen and chest in investigation of Cushing's syndrome. (1982) (34)
IMMUNOREACTIVE SOMATOSTATIN CHANGES DURING INSULIN‐INDUCED HYPOGLYCAEMIA AND OPERATIVE STRESS IN MAN (1980) (34)
Comparison of the redox assay for ACTH with previous assays. (1973) (34)
Acromegaly--results of long term treatment with bromocriptine. (1978) (33)
THE EFFECT OF LISURIDE HYDROGEN MALEATE, AN ERGOT DERIVATIVE ON ANTERIOR PITUITARY HORMONE SECRETION IN MAN (1979) (33)
SECRETION OF ACTH, LPH AND β‐ENDORPHIN FROM HUMAN PITUITARY TUMOURS IN VITRO (1980) (33)
Changes in plasma cortisol induced by dexamphetamine and chlordiazepoxide given alone and in combination in man. (1968) (33)
Urinary tri-iodothyronine excretion as index of thyroid function. (1972) (33)
Corticotrophin-releasing factor--mediated adrenocorticotrophin release from rat anterior pituitary cells is potentiated by C-terminal gastrin-releasing peptide. (1984) (33)
The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism (2003) (33)
Growth in Disorders of Adrenal Hyperfunction (2002) (32)
THE PARTICIPATION OF HYPOTHALAMIC DOPAMINE IN MORPHINE‐INDUCED PROLACTIN RELEASE IN MAN (1983) (32)
CRF-41 stimulates the release of β-lipotrophin and β-endorphin in normal human subjects (1984) (32)
Gender differences in incidence of idiopathic fistula-in-ano are not explained by circulating sex hormones (2004) (32)
Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis. (1983) (31)
Effect of adrenaline on basal and ovine corticotrophin-releasing factor-stimulated ACTH secretion in man. (1987) (31)
Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel (1967) (31)
Clinical use of a growth hormone receptor antagonist in the treatment of acromegaly (2001) (31)
A BROMOCRIPTINE‐RESPONSIVE CORTICOTROPH ADENOMA SECRETING α‐MSH IN A PATIENT WITH CUSHING'S DISEASE (1988) (31)
β‐ENDORPHIN AND β‐MSH IN HUMAN PLASMA (1980) (30)
ACTH AS A TUMOR MARKER (1977) (30)
THE ENDOCRINE AND METABOLIC EFFECTS OF CIMETIDINE (1983) (30)
Corticosteroid treatment and surgery. 2. The management of steroid cover. (1970) (30)
Cushing's disease in childhood (1996) (30)
SOMATOSTATIN SECRETION BY LUNG AND THYMIC TUMOURS (1980) (30)
EVIDENCE FOR THE PARTICIPATION OF ENDOGENOUS OPIOIDS IN THE SYMPATHOADRENAL RESPONSE TO HYPOGLYCAEMIA IN MAN (1985) (30)
Mania in association with hydrocortisone replacement for Addison's disease. (1992) (29)
Linkage analysis of 7 polymorphic markers at chromosome 11p11. 2‐11q13 in 27 multiple endocrine neoplasia type 1 families (1993) (29)
Gall stones and treatment with octreotide for acromegaly (1989) (29)
A study of 24-hour profiles of plasma met-enkephalin in man (1981) (29)
Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. (1990) (29)
Alpha 2-adrenoceptor agonists stimulate growth hormone secretion but have no acute effects on plasma cortisol under basal conditions. (1987) (29)
RISK FACTOR FOR MYOCARDIAL INFARCTION IN TRANSURETHRAL RESECTION OF PROSTATE? (1989) (29)
Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy (1999) (28)
Secondary forms of polycystic ovary syndrome (2004) (28)
THE EFFECT OF ALPHA ADRENERGIC MANIPULATION ON THE 24 HOUR PATTERN OF CORTISOL SECRETION IN MAN (1987) (28)
Colonic transit influences deoxycholic acid kinetics. (2001) (28)
The release of leptin and its effect on hormone release from human pituitary adenomas (2001) (28)
The time course of action of single doses of diazepam, chlorpromazine and some barbiturates as measured by auditory flutter fusion and visual flicker fusion thresholds in man. (1967) (28)
Characterisation of the pro opiocortin family of peptides in human cerebrospinal fluid. (1981) (27)
Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay. (1994) (27)
Plasma Cortisol Levels in Mania: Associated Clinical Ratings and Changes during Treatment with Haloperidol (1985) (27)
MANAGEMENT OF CRANIAL DIABETES INSIPIDUS WITH ORAL DESMOPRESSIN (DDAVP) (1986) (27)
CHLORPROMAZINE, HALOPERIDOL, METOCLOPRAMIDE AND DOMPERIDONE RELEASE PROLACTIN THROUGH DOPAMINE ANTAGONISM AT LOW CONCENTRATIONS BUT PARADOXICALLY INHIBIT PROLACTIN RELEASE AT HIGH CONCENTRATIONS (1980) (27)
Pyridostigmine enhances, but does not normalise, the GH response to GH-releasing hormone in obese subjects. (1990) (27)
PITUITARY AND TESTICULAR FIBROSIS IN ASSOCIATION WITH RETROPERITONEAL FIBROSIS (1980) (27)
Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I‐MIBG and 111In‐DTPA pentetreotide (1998) (26)
ACTH, LPH AND RELATED PEPTIDES IN THE ECTOPIC ACTH SYNDROME (1980) (26)
DETERIORATION OF SEVERE GRAVES' OPHTHALMOPATHY DURING CYCLOSPORIN TREATMENT (1984) (26)
Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome. (1999) (26)
Benzodiazepines attenuate the pituitary‐adrenal responses to corticotrophin‐releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome (1995) (26)
Digital Vasospasm with Bromocriptine (1976) (26)
The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature. (1985) (26)
EFFECTS OF THE H2 RECEPTOR ANTAGONIST CIMETIDINE ON PITUITARY HORMONES IN MAN (1979) (26)
High-dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects (1991) (25)
The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas (1991) (25)
HYPOTHALAMIC HORMONE INTERACTION IN ACROMEGALY (1975) (25)
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. (1991) (25)
Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease. (2010) (25)
Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment. (2000) (25)
The effect of surgery on plasma β-endorphin and methionine-enkephalin (1985) (25)
THE PITUITARY‐ADRENAL RESPONSE TO CRF‐41 IS UNALTERED BY INTRAVENOUS SOMATOSTATIN IN NORMAL SUBJECTS (1989) (25)
A cytochemical section-bioassay for thyrotropin. (1980) (24)
The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. (2001) (24)
Interaction between thyrotrophin, corticotrophin and growth hormone secretion in man. (1971) (24)
Effects of Oestrogen on Urinary Thyroxine Excretion (1972) (24)
Plasma levels of neuropeptide tyrosine Y (NPY) are increased in human sepsis but are unchanged during canine endotoxin shock despite raised catecholamine concentrations. (1988) (24)
Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia. (1998) (24)
Endorphin-related peptides in rat cerebrospinal fluid (1983) (23)
Hexarelin as a test of pituitary reserve in patients with pituitary disease (1999) (23)
Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone. (1989) (23)
Predicting Therapeutic Response and Degree of Pituitary Tumour Shrinkage during Treatment of Acromegaly with Octreotide LAR (2004) (23)
THE EFFECT OF CYPROTERONE ACETATE ON SERUM TESTOSTERONE, LH, FSH, AND PROLACTIN IN MALE SEXUAL OFFENDERS (1980) (23)
Effect of an opiate antagonist on the responses of circulating catecholamines and the renin-aldosterone system to acute sympathetic stimulation by hand-grip in man. (1986) (23)
Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects. (1981) (23)
Effect of cyclosporin A in male autoimmune infertility. (1986) (22)
COMPARISON OF THE PHARMACOKINETICS IN MAN OF TWO SYNTHETIC ACTH ANALOGES: a1–24 AND SUBSTITUTED β1–18 ACTH. (1977) (22)
Acceleration of pubertal development following pituitary radiotherapy for Cushing's disease. (1993) (22)
Massive prolactinoma with galactorrhoea in a prepubertal boy. (1989) (22)
Absence of uterine neoplasia in patients on bromocriptine. (1977) (22)
Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion. (2000) (22)
STILBOESTROL PRETREATMENT OF CHILDREN WITH SHORT STATURE DOES NOT AFFECT THE GROWTH HORMONE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE (1987) (22)
CSF AND PLASMA SOMATOSTATIN LEVELS IN ACROMEGALY (1980) (22)
MEASUREMENT OF IMMUNOREACTIVE γ‐MSH IN HUMAN PLASMA (1984) (21)
FAMILIAL HYPOCALCIURIC HYPERCALCAEMIA: ASSOCIATION WITH NEONATAL PRIMARY HYPERPARATHYROIDISM, AND POSSIBLE LINKAGE WITH HLA HAPLOTYPE (1984) (21)
Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine. (1980) (21)
Bromocriptine in the medical management of acromegaly. (1980) (21)
AN ANALOGUE OF MET‐ENKEPHALIN ATTENUATES THE PITUITARY‐ADRENAL RESPONSE TO OVINE CORTICOTROPHIN RELEASING FACTOR (1986) (21)
CORTICOTROPHIN RELEASING FACTOR: EFFECTS ON CIRCULATING GUT AND PANCREATIC PEPTIDES IN MAN (1984) (20)
The Endocrine Functions of the Brain (1982) (20)
THE ROLE OF OPIATE PEPTIDES IN THE CONTROL OF PROLACTIN IN THE PUERPERIUM, AND TSH IN PRIMARY HYPOTHYROIDISM (1982) (20)
The adrenocortical response to surgery and insulin-induced hypoglycemia in corticosteroid-treated and normal subjects. (1968) (20)
Prolonged Corticotrophic Action of a Synthetic Substituted α1-18 ACTH (1971) (19)
IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA (1988) (19)
Sex and smell--an enigma resolved. (1992) (19)
Treatment with GHRH(1‐29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity (1994) (19)
Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. (1995) (19)
Thyrotoxicosis: relations between clinical state and biochemical changes during carbimazole treatment. (1977) (18)
Differential effect of high-dose naloxone on the plasma adrenaline response to the cold-pressor test. (1989) (18)
Bromocriptine treatment of hyperprolactinaemic hypogonadism. (1978) (18)
SUCCESSFUL TREATMENT BY CHEMOTHERAPY FOR ACROMEGALY ASSOCIATED WITH ECTOPIC GROWTH HORMONE RELEASING HORMONE SECRETION FROM A CARCINOID TUMOUR (1990) (18)
Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial (2001) (18)
Pituitary-adrenal function in depression. (1968) (18)
Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophinreleasing hormone-41 in normal human subjects (1991) (18)
Endocrine Function in the Prader-Willi Syndrome (1978) (18)
Studies of the Hypothalamus and the Pituitary Gland (1976) (17)
Deletion analysis maps ocular albinism proximal to the steroid sulphatase locus (1993) (17)
Long-term effects of radiotherapy for acromegaly on circulating prolactin. (1989) (17)
‘Dynorphin’ in plasma: enzymatic artifact and authentic immunoreactivity (1984) (17)
Long‐term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia (2013) (17)
BROMOCRIPTINE-RESPONSIVE FORM OF IDIOPATHIC ŒDEMA (1979) (17)
GONADOTROPHIN RELEASING HORMONE THERAPY (1976) (17)
Turner's syndrome with coeliac disease, thin bones and abnormal liver function tests (1973) (16)
Two new modes of desmopressin (DDAVP) administration. (1980) (16)
NALOXONE PROVOKES CATECHOLAMINE RELEASE IN PHAEOCHROMOCYTOMAS AND PARAGANGLIOMAS (1986) (16)
The effects of ranitidine on pituitary hormone secretion in vitro. (1980) (16)
Effect of adrenergic antagonism on the growth hormone, prolactin and cortisol response to a synthetic opioid agonist in man. (1986) (16)
Specific electrocardiographic features associated with Cushing’s disease (2011) (16)
The effect of recombinant IGF‐I on anterior pituitary function in healthy volunteers (1994) (16)
Lipid mobilizing hormones of the hypothalamus and pituitary. (1975) (15)
The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol (1983) (15)
NORMAL CIRCULATING IMMUNOREACTIVE GROWTH HORMONE RELEASING FACTOR (hGRF) CONCENTRATIONS IN PATIENTS WITH FUNCTIONAL HYPOTHALAMIC hGRF DEFICIENCY (1986) (15)
Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man. (1995) (15)
Stimulation of Alpha‐Adrenoceptors Facilitates the Release of Growth Hormone‐Releasing Hormone from Rat Hypothalamus in vitro (1989) (15)
VALIDATION OF THE REDOX CYTOCHEMICAL ASSAY FOR CORTICOTROPHIN (1974) (15)
hCGβ PRODUCING PINEAL CHORIOCARCINOMA (1982) (15)
Effects of follicular phase exercise on luteinizing hormone pulse characteristics in sedentary eumenorrhoeic women (1994) (14)
Dissociation between circulating concentrations of immunoreactive growth hormone releasing factor and growth hormone in normal human subjects. (1987) (14)
Somatostatin octapeptide (SMS 201-995) in the medical treatment of acromegaly. (1986) (14)
Clinical evaluation of lysuride in the management of hyperprolactinaemia. (1987) (14)
HYPERPROLACTINAEMIA AND MICROADENOMAS IN PRIMARY HYPOTHYROIDISM (1987) (14)
PROLACTIN PULSATILITY IN PATIENTS WITH GONADAL DYSFUNCTION (1981) (14)
Modulation of the actions of tyrosine by α2‐adrenoceptor blockade (1988) (14)
The effect of enkephalin analogue on pituitary hormone release in human obesity. (1987) (14)
Time Course of Action of Diazepam (1967) (14)
Cystic islet cell tumors of the pancreas. (1998) (13)
COMPARISON OF LONG‐ACTING ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN MAN (1979) (13)
Prolactin and gonadal function. (1981) (13)
Bromocriptine in acromegaly. (1981) (13)
Failure of cimetidine to antagonise dopamine-induced suppression of prolactin in vitro. (1979) (13)
Dopaminergic control of the rat thyrotroph. (1983) (13)
METERGOLINE AND CYPROHEPTADINE SUPPRESS PROLACTIN RELEASE BY A NON‐5‐HYDROXYTRYPTAMINERGIC, NON‐DOPAMINERGIC MECHANISM (1980) (13)
Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro. (1996) (13)
Oral contraception in patients with hyperprolactinaemia. (1982) (13)
A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells. (1980) (13)
Visceral and skin granuloma annulare, diabetes, and polyendocrine disease. (1986) (12)
TWO NEW DOPAMINE AGONISTS THAT ARE LONG ACTING IN VIVO BUT SHORT ACTING IN VITRO (1980) (12)
Peptides related to alpha-melanocyte-stimulating hormone are commonly produced by human pituitary corticotroph adenomas: no relationship with pars intermedia origin. (1989) (12)
The pituitary fossa--normal or abnormal. (1976) (12)
Low dose prednisolone or oestrogen in the treatment of women with late onset or persistent acne vulgaris (1983) (12)
Release by amphetamine in man of growth hormone and corticosteroids: the effects of thymoxamine and propranolol. (1970) (12)
Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormone. (1983) (12)
Glucose-induced changes in somatostatin-14 and somatostatin-28 released from rat hypothalamic fragments 'in vitro'. (1984) (11)
Growth hormone releasing hormone. (1986) (11)
Identification of olfactory dysfunction in carriers of X‐linked Kallmann's syndrome (1994) (11)
Colorectal neoplasia in acromegaly (1999) (11)
ANALOGUES OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE (1975) (11)
Endocrine and Nonendocrine Hormone-producing Tumors (1974) (11)
EFFECT OF SOMATOSTATIN ON ABNORMAL GROWTH HORMONE AND PROLACTIN SECRETION IN PATIENTS WITH THE CARCINOID SYNDROME (1979) (11)
Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes. (1976) (11)
PLEUROPULMONARY SHADOWS ON BROMOCRIPTINE (1981) (11)
Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro. (1985) (11)
Tumour ACTH Concentrations in Ectopic ACTH Syndrome and in Control Tissues (1971) (11)
Auditory flutter fusion as a measure of the actions of centrally acting drugs: modification of the threshold for fusion and the influence of adapting stimuli. (1967) (11)
Gamma‐Aminobutyric Acid Modulation of Corticotrophin‐Releasing Factor‐41 Secretion from the Rat Hypothalamus in vitro (1990) (11)
Proceedings: Inhibition of gastrin and gastric acid by growth hormone release inhibiting hormone. (1975) (10)
Clinical diabetes : an illustrated text (1988) (10)
ACTH, LPH, and beta-endorphin secretion from perfused isolated human pituitary tumour cells in vitro. (1980) (10)
Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone. (1992) (10)
The medical management of hormone-secreting tumors of the pituitary. (1983) (10)
Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitro. (1991) (10)
Observations on the function of normal adrenomedullary tissue in patients with phaeochromocytomas and other paragangliomas (2004) (10)
Similar high molecular weight forms of growth hormone-releasing hormone are found in rat brain and testis. (1991) (10)
Long‐term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia (1990) (10)
Effect of histamine infusion on circulating methionine-enkephalin and catecholamine concentrations (1985) (10)
In vitro studies on the effects of ranitidine on isolated anterior pituitary and adrenal cells. (1981) (10)
Growth Hormone Releasing Hormone in the Assessment and Long‐term Treatment of Growth Hormone Deficiency (1987) (10)
Characterisation by high performance liquid chromatography of circulating growth hormone releasing factors in a human plasma. (1985) (9)
Growth Hormone Response to Overnight Growth Hormone‐Releasing Hormone Infusion and Oral Pyridostigmine in Children with Short Stature (1989) (9)
THE EFFECTS OF SUBMAXIMAL ENDURANCE EXERCISE UPON LH PULSATILITY (1990) (9)
The detection of peaks in luteinizing hormone secretion. (1989) (9)
Variable methylation of the 5'-flanking DNA of the human pro-opiomelanocortin gene. (1991) (9)
Characterization of immunoreactive dynorphin in human phaeochromocytomas. (1988) (9)
Hypothalamus as an endocrine organ. II. (1974) (9)
DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME (1986) (9)
Asynchronous changes in circulating LH and FSH after the gonadotrophin releasing hormone. (1973) (9)
THE EFFECT OF OVINE CORTICOTROPHIN‐RELEASING FACTOR ON THE HORMONAL RESPONSE TO INSULIN‐INDUCED HYPOGLYCAEMIA (1989) (9)
Opioid Peptides in Humans and Their Clinical Significance (1984) (9)
SERUM TSH RESPONSES TO INTRAVENOUSLY AND ORALLY ADMINISTERED TRH IN MAN AFTER THYROIDECTOMY FOR CARCINOMA OF THE THYROID (1973) (9)
ACTH AND MSH ASSAYS AND THEIR CLINICAL APPLICATION (1973) (9)
The potential for growth hormone in the management of heart failure. (1997) (9)
Experience with Selective Venous Sampling in Diagnosis of ACTH-Dependent Cushing’s Syndrome (1982) (9)
Plasma corticosteroids in mania: The effects of pimozide (1980) (8)
Handbook of Physiology (1975) (8)
Mithramycin treatment of malignant hypercalcaemia. (1968) (8)
Effects of treatment on tyrosine tolerance in thyroid disease. A modified tyrosine assay. (1971) (7)
Importance of Early Tumour Exacerbation in Patients Treated With Long Acting Analogues of Gonadotropin Releasing Hormone for Advanced Prostatic Cancer (1986) (7)
CORTICOTROPIN-RELEASING FACTOR IN THE ALIMENTARY TRACT (1983) (7)
Normal final height and apparent cure after pituitary irradiation for Cushing's disease in childhood: long‐term follow‐up of anterior pituitary function (1998) (7)
The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol and thyroid stimulating hormone in healthy elderly men. (1992) (7)
Luteinizing hormone secreting adrenal tumour as a cause of precocious puberty (1998) (7)
Clinical Endocrinology : an illustrated text (1987) (7)
The first clinical use of depot buserelin for advanced prostatic carcinoma (2004) (7)
SUBCUTANEOUS GROWTH HORMONE‐RELEASING HORMONE AUGMENTS PULSATILE NOCTURNAL GH RELEASE IN GH‐INSUFFICIENT CHILDREN, BUT MAY ALSO RAISE BASAL GH SECRETION (1990) (7)
Medical Management of Acromegaly with Bromocriptine Effects of Continuous Treatment for Over Three Years (1978) (7)
Opioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man. (1988) (7)
Second brain tumour after treatment for pituitary adenoma. (1992) (7)
Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia (1989) (7)
Complications of inferior petrosel sinus sampling. (2000) (7)
Adrenal vein and arterial levels of catecholamines and immunoreactive metenkephalin in canine endotoxin shock and their response to naloxone (1988) (7)
Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. (1991) (7)
Beta-lipotrophin in human plasma and cerebrospinal fluid: radioimmunoassay evidence for gamma-lipotrophin and beta-endorphin [proceedings]. (1978) (6)
Corticotrophin-like peptide concentrations in the intermediate lobe of rat and guinea-pig pituitaries. (1972) (6)
[The interaction of chlordiazepoxide and dexamphetamine in man]. (1967) (6)
Proceedings: Indroduction of a new stimulation test for prolactin: the sulpiride test; a comparison with other dynamic function tests. (1974) (6)
Effect of liver and renal dysfunction on circulating methionine-enkephalin immunoreactivity (1985) (6)
Apathetic T-3 toxicosis. (1974) (6)
BETA-ADRENERGIC AGONISTS AND CORTICOTROPIN SECRETION (1985) (6)
Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumours. (1998) (6)
Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years. (2002) (6)
Measurement of immunoreactive gamma-MSH in human plasma. (1984) (6)
A specific radioimmunoassay for human beta-lipotropin. (1978) (6)
ARE THERE GENETIC DETERMINANTS FOR THE GLUCOSE INTOLERANCE OF ACROMEGALY? (1985) (5)
Quantitative cytochemistry in the detection and analysis of sensitive rapid effects of hormones. (1979) (5)
Letter: Antiemetics, prolactin, and breast cancer. (1974) (5)
Proceedings: Asynchronous pulsatile luteinizing hormone and follicle-stimulating hormone responses during luteinizing hormone-follicle-stimulating hormone releasing hormone and thyroid-stimulating hormone releasing hormone infusions. (1973) (5)
Response to thyrotrophin-releasing hormone. (1971) (5)
An in-situ isolated rat adrenal perfusion system for study of neurally mediated catecholamine secretion: effects of morphine, a Met-enkephalin analogue, and naloxone on catecholamine secretion. (1986) (5)
Proceedings: Measurable effects of low concentrations (100 fg/ml) of thyrotrophin releasing hormone. (1975) (5)
Clinical Neuroendocrine Relationships in Normal and Disordered Prolactin Secretion (1979) (5)
Met-enkephalin and related peptides in man. (1982) (5)
Proceedings: The relationship between prolactin and gonadotrophins: effects of clomiphene administration in normal men. (1974) (5)
A phylogenetic study of pituitary corticotrophic activity. (1971) (5)
The effects on anterior pituitary hormone secretion of salmon calcitonin in healthy volunteers (1991) (5)
Clinical implications of growth hormone release inhibiting hormone (GH-RIH). (1976) (5)
Adrenocorticotrophin and Lipotrophin in Pituitary-Adrenocortical Diseases (1981) (5)
Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotide (1995) (5)
Characterization by high-performance liquid chromatography of circulating growth hormone-releasing factors in normal subjects. (1986) (5)
Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy (1996) (5)
The mechanism whereby growth hormone-release inhibiting hormone (somatostatin) inhibits food stimulated gastric acid secretion in the cat (1975) (5)
Prolactin and gonadal function. (1981) (4)
Proceedings: Investigation and treatment of a recurrent vipoma. (1975) (4)
Plasma corticotrophin levels in primary and secondary adrenocortical insufficiency. (1969) (4)
Hypothalamic Regulating Hormones (1983) (4)
Errors of Phenylalanine Thyroxine and Testosterone Metabolism (1971) (4)
Successful treatment of acromegaly with bromocriptine. (1976) (4)
The molecular basis of parathyroid tumours in multiple endocrine neoplasia type 1 (1990) (4)
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomant. (2002) (4)
Symposium on pituitary tumors. (1980) (4)
Opiate Mediation of Amenorrhoea in Hyperprolactinaemia and in Weight Loss-related Amenorrhoea (1983) (4)
Alteration of prolactin secretion by centrally acting drugs. (1980) (4)
Somatostatin Octapeptide (SMS 201–995, Sandostatin®) in the Medical Treatment of Acromegaly (1988) (4)
Hyperprolactinaemia–Hypogonadism Syndromes (1978) (4)
HYPOTHALAMIC-PITUITARY EFFECTS OF CIMETIDINE (1978) (4)
Neuroendocrine and cardiovascular responses to high-dose corticosteroid therapy in canine endotoxin shock (1988) (4)
No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience. (2010) (3)
Proceedings: The induction of gonadotrophin secretion with repeated subcutaneous injections of luteinizing hormone-follicle-stimulating hormone releasing hormone in men with hypogonadotrophic hypogonadism. (1974) (3)
CRF-41 stimulates the release of beta-lipotrophin and beta-endorphin in normal human subjects. (1984) (3)
HETEROGENEITY OF HUMAN GROWTH HORMONE IN PLASMA AND URINE: INFLUENCE OF GROWTH HORMONE RELEASE INHIBITING HORMONE (1975) (3)
Plasma catecholamine levels in porcine Escherichia coli septicaemia and following treatment with buprenorphine or naloxone. (1993) (3)
hCG beta producing pineal choriocarcinoma. (1982) (3)
Bromocriptine and endocrine disorders. (1979) (3)
Proceedings of the workshop, "Practical approaches to the diagnosis and treatment of acromegaly". (1992) (3)
Chromatographic characterization of adsrenocorticotrophin in human plasma. (1980) (3)
The effects of a met-enkephalin analogue on ACTH, beta-LPH, beta-endorphin and MET-enkephalin in patients with adrenocortical disease. (1981) (3)
Calcium and calmodulin mediation of growth hormone-releasing hormone release from the rat hypothalamus in vitro. (1991) (3)
Differential diagnosis in Cushing's syndrome: the role of inferior petrosal sinus sampling. (1993) (3)
Thymoxamine: lack of antihistaminic effects in clinical doses in man. (1987) (3)
The luteinizing hormone (LH) and follicle-stimulating hormone response to synthetic LH releasing factor in man. (1972) (3)
The effects of a gonadotropin-releasing hormone agonist on testicular histology. (1987) (3)
The pharmacology of post prandial somatostatin release in man (1983) (3)
PROLACTIN AND IDIOPATHIC OLIGOSPERMIA (1979) (3)
Hirsutes. (1971) (3)
The Use of Dopamine Agonists in the Management of Acromegaly (1987) (2)
Bromocriptine and uterine neoplasia (1977) (2)
Late diagnosis of pituitary and parapituitary lesions causing visual failure. (1986) (2)
Effects of TRH on and Interaction with Other Pituitary Hormones (1972) (2)
Mammary Cancer and Neuroendocrine Therapy (1975) (2)
The influence of plasma on basal and ACTH-stimulated in vitro adrenocortical steroidogenesis. (1999) (2)
Letter: Digital vasospasm with bromocriptine. (1976) (2)
Bromocriptine Treatment ofAcromegaly (1975) (2)
Cortisol Circadian Rhythm (1967) (2)
Treatment of prolactinomas with megavoltage radiotherapy. (1984) (2)
External Radiation Therapy of Acromegaly (1988) (2)
Urinary thyroxine excretion. (1972) (2)
Mechanism of o,p′-DDD-induced hypercholesterolaemia in patients with cushing's disease (1990) (2)
Secretion of ACTH, LPH and beta-endophin from human pituitary tumours in vitro. (1980) (2)
Hypothalamic regulatory hormones: physiological and clinical implications. (1978) (2)
The urinary excretion of thyroid hormones. (1972) (2)
DOPAMINE AND INHIBITION OF PROLACTIN AND GROWTH-HORMONE SECRETION (1976) (2)
Bromocriptine in management of large pituitary tumours. (1982) (2)
The role of computed tomography and venous sampling in the investigation of hyperaldosteronism (conn's syndrome) (1993) (2)
Prolactinomas. (1985) (2)
Gamma knife radiosurgery: a safe and effective treatment for acromegaly (2008) (1)
Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitro. (1989) (1)
Quantitative growth hormone secretion and final adult height (1999) (1)
P-5-616 Investigation, management and treatment outcome in 100 patients with Cushings' disease, following transsphenoidal surgery (1997) (1)
Hirsuties and virilism (1972) (1)
Response to Growth Hormone‐Releasing Hormone as Evidence of Hypothalamic Defect in Optic Nerve Hypoplasia (1989) (1)
Pharmacological Control of Post Prandial Plasma Somatostatin in Man (1983) (1)
Growth hormone releasing hormone. (1985) (1)
Growth hormone-releasing hormone: a new treatment for growth hormone deficiency (1989) (1)
Regular Review Prolactinomas (2006) (1)
Book Review: Prolactin, Vol 7 (1980) (1)
Dissociation of the plasma disappearance of bioactive and immunoreactive ACTH from human plasma. (1970) (1)
Authors’ Response: Discriminatory Value of Low-Dose Dexamethasone Suppression Test in Establishing the Diagnosis and Differential Diagnosis of Cushing’s Syndrome (2004) (1)
Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children. (1986) (1)
Somatostatin Octapeptide in the Medical Treatment of Acromegaly (1987) (1)
The actions of growth hormone release inhibiting hormone in man (1975) (1)
Treatment With Gonadotrophin Releasing Hormone Analogue in Advanced Prostatic Cancer (1983) (1)
Differential diagnosis of Cushing's syndrome. (1986) (1)
The effect of surgery on plasma beta-endorphin and methionine-enkephalin. (1985) (1)
Detection of hormone fragments. (1972) (1)
55 Prolactinoma in a prepubertal child: response to Surgery, radiotherapy and dopamine agonist therapy (1985) (1)
The regulation of prolactin release by the anterior pituitary [proceedings]. (1979) (1)
Tyrosine tolerance in thyroid disease. (1968) (1)
ENHANCING HYPOTHALAMIC LESIONS SHOWN ON HIGH RESOLUTION COMPUTERIZED TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM (1986) (1)
Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly. (1983) (1)
First International Workshop on Growth Hormone, Insulin-like Growth Factors and Neoplasia (2000) (1)
Effect of serotonin on prolactin secretion in vitro. (1980) (1)
Visual field improvement induced by bromocriptine treatment. (1987) (1)
How Common Are Polycystic Ovaries and the Polycystic Ovarian Syndrome in Women With Cushing’s Syndrome? (2001) (1)
GASTROINTESTINAL BLEEDING IN PATIENTS ON BROMOCRIPTINE (1976) (1)
Practical use of plasma immunoreactive ACTH measurements. (1971) (1)
Development of a cytochemical section-assay for thyroid stimulators [proceedings]. (1977) (1)
43 Growth hormone profiles in GH-deficient children on and off twice daily sc GHRH therapy and during a sc infusion of GHRH (1988) (1)
Parafibromin germline mutations in patients with parathyroid tumours (2003) (0)
beta-Endorphin and beta-MSH in human plasma. (1980) (0)
Luteinizing Hormone andFollicle Stimulating Hormone- Releasing Hormone TestinPatients withHypothalamic- Pituitary-Gonada l Dysfunction (1973) (0)
Book Review: Essentials of Clinical Endocrinology (1971) (0)
Advances in Endocrine Surgery [Abridged] (1970) (0)
CASEREPORTS Turner's syndrome withcoeliac disease, thin bones andabnormal liver function tests (1973) (0)
Valueofcomputed tomography oftheabdomenandchest ininvestigation ofCushing's syndrome (1982) (0)
Essentials of Clinical Endocrinology (1971) (0)
Proceedings: Measurement of plasma adrenocorticotrophin levels in normal and hypopituitary subjects by redox bioassay. (1973) (0)
Virilizing Ovarian Tumour and Polycystic Ovary Syndrome (1972) (0)
Book Review: The Endocrine Functions of the Brain (1982) (0)
Physiology of adrenal cortical function. (1972) (0)
The effects of stilbestrol pretreatment on the GH response to insulin hypoglycemia and GHRH - evidence for a hypothalamic site of action (1986) (0)
Surgical implications of medullary carcinoma of the thyroid. (1970) (0)
Book Review: The Adrenal Gland (1980) (0)
Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings]. (1979) (0)
ACTH Concentrations in Non-Endocrine Tumours (1972) (0)
Recent studies in normal and abnormal growth hormone secretion (2001) (0)
LETTERS TO THE EDITORS (1990) (0)
Pyridostigmine fails to increase either spontaneous or GHRH‐stimulated GH secretion during day or night in growth hormone‐insufficient children (1991) (0)
A phase II study of interferon alpha-2a (IFNα) and modulated 5-f1uorouracil (5-FU)in patients (pts) with advanced neuroendocrine tumours (NET) (1997) (0)
The Prevention of Octreotide-Induced Gallstones—Does Cisapride Overcome the Effects of Octreotide on Gallbladder Emptying? (1997) (0)
Peripituitary tumour surveillance imaging in patients receiving growth hormone replacement (2005) (0)
Geometric Means and Ranges for Plasma Tyrosine Concentration ( jig / mI ) during Oral Tyrosine Tolerance Tests in Normal Subjects and in Patients with Thyroid Disease , before and after Treatment (2004) (0)
Possible involvement of polyamines in the response of thyroid follicle cells to thyrotrophin [proceedings]. (1978) (0)
Book Review: Endocrine and Nonendocrine Hormone-Producing Tumors (1974) (0)
The effect of spermidine on lysosomes in thyroid follicle cells [proceedings]. (1977) (0)
Occasional Survey Hypothalamus as an Endocrine Organ *-II (2006) (0)
Clinical value of the gonadotrophin releasing hormone. (1974) (0)
Book Review: Errors of Phenylalanine Thyroxine and Testosterone Metabolism (1971) (0)
Effect of Opiate Receptor Blockade on the Cardiovascular and Plasma Noradrenaline Response to Intravenous Tyramine in Man (1988) (0)
Combined use of vasopressin and synthetic hypothalamic releasing factors as test of anterior pituitary function (1986) (0)
Pituitary and hypothalamic physiology. (1976) (0)
Book Review: Fundamentals of Clinical Endocrinology (1970) (0)
Somatostatin secretion by non-endocrine tumours (1980) (0)
A new operation for adrenal pathology: laparoscopically-assisted mini-adrenalectomy (2004) (0)
Introduction (1975) (0)
Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: alpha1-24 and substituted alpha1-18 ACTH. (1977) (0)
Reply (2001) (0)
Role of Fasting Plasma Glucose, Glycated Haemoglobin and Homeostatic Model Assessment in the Detection of Glucose Intolerance in Adult Hypopituitary Patients during Growth Hormone Replacement Therapy (2007) (0)
Normalisation of serum IGF-I by pegvisomant is not associated with a reduction in median nerve size in patients with active acromegaly (2003) (0)
The Effects of Endogenous Catecholamines on the Hypothalamo-Pituitary Adrenal Axis in Man (1989) (0)
LETTER TO THE EDITORS (1987) (0)
Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis : Clinical , Endocrinological , and Radiological Features and Response to Treatment (2000) (0)
A rapid method for analysing serum pro-insulin-like growth factor-II (pro-IGF-II) in patients with non-islet cell tumour hypoglycaemia (NICTH) (2003) (0)
Long-Term Treatment with a New Repeatable Form of Bromocriptine, Parlodel LAR, Patients with Tumorous Hyperprolactinemia (1990) (0)
Effects of the gonadotrophin releasing hormone in patients with hypothalamic pituitary-gonadal diseases. (1974) (0)
Proceedings of the Physiological Society, 17‐18 March 1967, University College Meeting: Communications (0)
Evaluation of clinical disturbances of the hypothalamus (1978) (0)
Letter: Dopamine and inhibition of prolactin and growth-hormone secretion. (1976) (0)
Proceedings: Thyrotoxicosis: relationship between clinical status, pituitary-thyroid function, and sex hormone-binding globulin levels on carbimazole therapy. (1975) (0)
Responses of serum GH and somatomedin-C to an analogue of GHRH in children with growth hormone deficiency (1984) (0)
Hypothalamic-pituitary tumour surveillance imaging in patients receiving growth hormone replacement (2000) (0)
Citokines modulate the release of CRH-41 from rat hypothalamic explants in vitro (1990) (0)
Prepubertal Cushing's disease: diagnosis and therapeutic outcome (2008) (0)
Letter: Analogues of growth-hormone release-inhibiting hormone. (1975) (0)
Hypochlorhydria Reduces Plasma Somatostatin Response to Food (1982) (0)
Growth hormone-releasing hormone-treatment of growth-hormone deficient children (1986) (0)
Gonadal Function in Hodgkin’s Disease: Long-Term Follow-Up of Chemotherapy (1983) (0)
Ectopic production ofmethionine enkephalin (1980) (0)
GERM CELL NEOPLASIA IN PATIENTS WITH ABNORMAL SEXUAL DIFFERENTIATION (1986) (0)
Acromegaly: Symposium on Somatostatin Analogues - Peptide Therapy in Action, London, January 1989: Proceedings (1990) (0)
Book Review: Aldosterone (1972) (0)
Subject Index Vol. 58, Suppl. 1, 2002 (2002) (0)
CHROMOSOME-11 ABNORMALITIES IN PARATHYROID TUMORS OF PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-I (MENTI) (1989) (0)
Atlas of Endocrine Imaging (1993) (0)
Histochemistry of the adenohypophysis. Volume VIII (suppl.). Part 4 of the Handbook of histochemistry. By C. Girod. 1976. Stuttgart: Gustav Verlag. Pp. 325. DM198 (1977) (0)
O-053. Acromegaly, colonic polyps and carcinoma (1997) (0)
The Role of Intestinal Transit in the Pathogenesis of Octreotide-Induced Gallbladder Stones (1998) (0)
Evidence that growth hormone inhibits the growth hormone response to growth hormone releasing factor in man (1985) (0)
14th International Symposium on Growth and Growth Disorders : proceedings of a meeting held in Budapest, Hungary, 23-24 October 1992 (1993) (0)
Elevated serum IGF-I is associated with an increased risk of colorectal neoplasia in acromegaly (1998) (0)
56 Cranial irradiation for cerebral tumors in childhood–evidence for a hypothalamic defect in growth hormone release (1985) (0)
Octreotide (2021) (0)
Lack of modulation of the adrenocortical response to ACTH by an opioid peptide. (1991) (0)
Handbook of Physiology (1975) (0)
FUTURE OF BART'S PRECLINICAL SCHOOL (1986) (0)
Clinical applications of the luteinizing hormone-follicle-stimulating releasing hormone. (1973) (0)
Galactorrhoea. (1972) (0)
NEED FOR STEROID REPLACEMENT THERAPY AFTER BILATERAL ADRENALECTOMY FOR CUSHING'S DISEASE (1982) (0)
Excision of phaeochromocytoma and paraganglioma involving the great vessels (2015) (0)
Modulation oftheactions oftyrosine by oC2-adrenoceptor blockade (1988) (0)
Hormonal Responses toSynthetic Luteinizing Hormoneand Follicle Stimulating Hormone-Releasing (1972) (0)
Pictorial review MRI of pancreatic neuroendocrine tumours (2001) (0)
Proceedings: Effect of growth hormone release inhibiting hormone on the release of growth hormone and other pituitary hormones in man. (1974) (0)
Elevated adrenocorticotropic hormone and cortisol levels in a patient with medullary carcinoma of the thyroid containing ectopic immunoreactive corticotropin-releasing hormone and bombesin (1991) (0)
CYPROTERONE ACETATE (1976) (0)
Cyclical Cushing's syndrome: prevalence in patients with Cushing's disease (2008) (0)
The effects of octreotide on the kinetics of deoxycholic and cholic acid (1998) (0)

This paper list is powered by the following services:

G. Michael Besser's Academic­Influence.com Rankings

G. Michael Besser's Degrees

Why Is G. Michael Besser Influential?

G. Michael Besser's Published Works

Published Works

G. Michael Besser's AcademicInfluence.com Rankings